Clinigen And Tepsivo Partner To Revolutionize Pharmacovigilance With AI Technology

Clinigen, a global leader in pharmaceutical services, has announced a new partnership with Tepsivo, a company specialising in digital Pharmacovigilance (PV) services. As part of this collaboration, Clinigen has also acquired a minority share in Tepsivo. Tepsivo offers its innovative PV platform, which is enabled by artificial intelligence and other digital tools. This all-in-one system ensures more streamlined, effective, and economical PV processes.

Nihad Hasagic, SVP of Strategic Initiatives at Clinigen, said, “This strategic partnership reflects our confidence in Tepsivo’s automated pharmacovigilance platform and its ability to modernise pharmacovigilance services. Together, we are expanding the range of digital PV solutions available to our clients and paving the way for a future where technology drives more efficient drug development.”

Using its global network and centralised coordination, Tepsivo helps pharmaceutical and biotech companies improve safety monitoring, meet regulatory requirements, and streamline their PV operations. This partnership reflects the shared vision of Clinigen and Tepsivo to leverage digital innovation in modernising PV programs for faster, more reliable safety monitoring and compliance in the pharmaceutical industry.

Tepsivo co-founder Dominik Hodbod commented, “Tepsivo was built to redefine pharmacovigilance by integrating digital innovations, including advanced AI, into every aspect of our platform to provide the highest level of compliance at the lowest cost. By partnering with Clinigen, we can accelerate our mission to deliver innovative digital PV solutions to a global audience, empowering clients with tools that enable scientists to focus on real science and improve compliance and patient safety.”

“Tepsivo’s technology offers clients an additional truly modern and future-proof approach to pharmacovigilance services. By combining their innovative platform with Clinigen’s deep expertise in pharmacovigilance, regulatory affairs, and medical information within our Lifecycle Services business unit, we’re equipping clients with the solutions they need to stay ahead in an increasingly complex regulatory landscape,” said Merav Edan, SVP of PV, Regulatory Affairs, and Medical Information Operations at Clinigen.